SBI Securities’s IN8bio INAB Stock Holding History

SBI Securities’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34	Closed	-$167	–	4186
2025 Q1	$167	Buy	+34	New	+$271	﹤0.01%	3281
2024 Q4	–	Hold	0	–	–	–	4061

Other funds holding INAB

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities's INAB Position: Q2 2025 in Review

SBI Securities sold out of IN8bio (INAB) in Q2 2025, closing a stake of 34 shares — an estimated $167 sold.

SBI Securities first reported a position in INAB in Q1 2025 and held it in 1 quarter. The position peaked at $167 in Q1 2025. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

SBI Securities reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
SBI Securities sold 34 IN8bio shares in Q2 2025, an estimated $167.
SBI Securities first reported a position in IN8bio in Q1 2025 and held it in 1 quarter.
SBI Securities's IN8bio position peaked at $167 in Q1 2025.
12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.